Why the study?
Does cardiac-directed expression of ACVI increase responsiveness to catecholamine stimulation in transgenic mice?
Does cardiac-directed expression of ACVI increase responsiveness to catecholamine stimulation in transgenic mice?
Overexpressing adenylylcyclase VI in the heart safely increases cardiac responsiveness to beta-adrenergic stimulation without causing detrimental continuous activation.
Answers are grounded in this paper and cite their sources.
Suggests ACVI overexpression as a targeted strategy to enhance beta-adrenergic responsiveness without toxicity; leaves open translation to human heart failure therapies.
BACKGROUND: The cellular content of cAMP generated by activation of adenylylcyclase (AC) through the beta-adrenergic receptor (betaAR) is a key determinant of a cell's response to catecholamine stimulation. We tested the hypothesis that increased AC content, independently of betaAR number, increases responsiveness to catecholamine stimulation in vivo. METHODS AND RESULTS: Transgenic mice with cardiac-directed expression of ACVI showed increased transgene AC expression but no change in myocardial betaAR number or G-protein content. When stimulated through the betaAR, cardiac function was increased, and cardiac myocytes showed increased cAMP production. In contrast, basal cAMP and cardiac function were normal, and long-term transgene expression was not associated with abnormal histological findings or deleterious changes in cardiac function. CONCLUSIONS: The amount of AC sets a limit on cardiac beta-adrenergic signaling in vivo, and increased AC, independent of betaAR number and G-protein content, provides a means to regulate cardiac responsiveness to betaAR stimulation. Overexpressing an effector (AC) does not alter transmembrane signaling except when receptors are activated, in contrast to receptor/G-protein overexpression, which yields continuous activation and has detrimental consequences. Our findings establish the importance of AC content in modulating beta-adrenergic signaling in the heart, suggesting a new target for safely increasing cardiac responsiveness to betaAR stimulation.
No takes yet. Share an insight, caveat, or question.
Gao et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: